Skip links

Insulin Overpricing MDL Claims

Mass Torts & Environmental Law Firm, LLC, LLC is now reviewing cases related to the Insulin Overpricing Multidistrict Litigation (MDL). If your organization is a large employer, union, government agency, school board, or university that self-funds its healthcare costs, you may be entitled to substantial compensation due to inflated insulin pricing. Call us today at (803) 247-3388 to learn more about your eligibility and take the first step toward recovering financial losses.

What Is the Insulin Overpricing MDL?

The Insulin MDL consolidates lawsuits from across the country that allege insulin manufacturers and pharmacy benefit managers (PBMs) engaged in a scheme to artificially inflate the price of insulin—causing devastating financial impacts on large organizations with self-funded healthcare plans.

The litigation centers around claims that major insulin manufacturers, including:

  • Novo Nordisk
  • Eli Lilly
  • Sanofi

collaborated with PBMs like:

  • CVS Caremark
  • Express Scripts
  • OptumRx

to manipulate insulin pricing through rebate-driven agreements. These agreements allowed manufacturers to keep insulin on PBM-preferred formularies while inflating list prices—leaving self-funded plans footing the bill for billions in unnecessary costs.

Free Case Evaluation

By submitting this form and signing up for texts, you consent to receive informational text messages regarding case details, and ask for the documents, including status updates and reminders for important dates or notifications, from Mass Torts & Environmental Law Firm, LLC at the number provided, including messages sent by an autodialer. Consent is not a condition of purchase. Message & data rates may apply. Message frequency varies. Unsubscribe at any time by replying STOP. Reply HELP for help. Privacy Policy and Terms & Conditions.

Who Is Eligible to File a Claim?

The following entities may qualify to participate in the insulin overpricing litigation:

  • Corporations with self-funded health plans
  • Labor unions covering employees’ medical costs
  • State, county, and municipal governments
  • Public and private universities
  • School boards and districts
  • Hospital systems and large medical centers

If your organization has paid for employee insulin prescriptions and operates a self-insured health plan, you may be eligible for treble damages—three times your actual financial loss—under civil litigation statutes.

What the Lawsuits Allege

The MDL claims that insulin manufacturers and PBMs violated multiple federal and state laws, including:

  • RICO (Racketeer Influenced and Corrupt Organizations Act)
  • Consumer protection statutes
  • Deceptive trade practices
  • Unjust enrichment

Through a rebate-driven pricing model, PBMs received kickbacks from manufacturers to ensure their insulin products remained on insurance formularies—regardless of cost-effectiveness. As a result, insulin prices in the U.S. have skyrocketed to 4–5 times what they should be, harming payers and patients alike.

What Damages May Be Recovered?

If your entity has been overcharged, a successful claim may recover:

  • Reimbursement of overpaid insulin claims
  • Treble damages for inflated costs
  • Punitive damages against manufacturers and PBMs
  • Injunctive relief to prevent future abuse of pricing mechanisms

This case presents a rare opportunity for large employers and agencies to recoup years of overpayments and help correct long-standing abuses in pharmaceutical pricing systems.

Why Timely Action Matters

The insulin MDL was consolidated in late 2023 in the U.S. District Court of New Jersey and is actively moving forward. Early claimants may have access to greater control over litigation outcomes, stronger documentation, and better settlement positioning.

If your organization has not yet filed a claim, now is the time to act. Waiting too long may reduce your ability to:

  • Preserve critical documentation
  • Join collective bargaining groups
  • Maximize financial recovery

Our firm can assess your records and determine your eligibility at no cost or risk to you.

Why Choose Mass Torts & Environmental Law Firm, LLC, LLC?

Mass Torts & Environmental Law Firm, LLC, LLC is a South Carolina-based law firm with decades of experience in complex civil litigation, class actions, and multidistrict litigation. We are committed to helping our clients—especially public institutions and employee benefit groups—seek justice when financial misconduct occurs.

Here’s what we offer:

  • No upfront fees – We advance all costs
  • No recovery, no fee – You only pay if we win
  • Experienced legal team – Skilled in MDLs and large-scale fraud cases
  • Free consultation – Call now to see if you qualify

We understand how burdensome skyrocketing healthcare costs can be for employers and plan sponsors. Let our team advocate for your financial recovery while you continue serving your employees or community.

Get Help with Your Insulin Overpricing Claim

If your organization has self-funded its health care and paid for insulin prescriptions over the past several years, you may be owed compensation. Call Mass Torts & Environmental Law Firm, LLC, LLC at (803) 247-3388 today for a free consultation. We’ll review your eligibility and help you file a claim before critical deadlines pass.

Let us help you hold pharmaceutical giants accountable for deceptive pricing practices that have harmed employers, unions, and public entities across the country.